Your browser doesn't support javascript.
loading
Evolution of MET and NRAS gene amplification as acquired resistance mechanisms in EGFR mutant NSCLC.
Peters, T L; Patil, T; Le, A T; Davies, K D; Brzeskiewicz, P M; Nijmeh, H; Bao, L; Camidge, D R; Aisner, D L; Doebele, R C.
Afiliación
  • Peters TL; Department of Medicine, Division of Medical Oncology, University of Colorado- Anschutz Medical Campus, Aurora, CO, USA.
  • Patil T; Department of Medicine, Division of Medical Oncology, University of Colorado- Anschutz Medical Campus, Aurora, CO, USA.
  • Le AT; Department of Medicine, Division of Medical Oncology, University of Colorado- Anschutz Medical Campus, Aurora, CO, USA.
  • Davies KD; Department of Pathology, University of Colorado- Anschutz Medical Campus, Aurora, CO, USA.
  • Brzeskiewicz PM; Department of Pathology, University of Colorado- Anschutz Medical Campus, Aurora, CO, USA.
  • Nijmeh H; Department of Pathology, University of Colorado- Anschutz Medical Campus, Aurora, CO, USA.
  • Bao L; Department of Pathology, University of Colorado- Anschutz Medical Campus, Aurora, CO, USA.
  • Camidge DR; Department of Medicine, Division of Medical Oncology, University of Colorado- Anschutz Medical Campus, Aurora, CO, USA.
  • Aisner DL; Department of Pathology, University of Colorado- Anschutz Medical Campus, Aurora, CO, USA.
  • Doebele RC; Department of Medicine, Division of Medical Oncology, University of Colorado- Anschutz Medical Campus, Aurora, CO, USA. robert.doebele@cuanschutz.edu.
NPJ Precis Oncol ; 5(1): 91, 2021 Oct 12.
Article en En | MEDLINE | ID: mdl-34642436

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: NPJ Precis Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: NPJ Precis Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos